American Academy of Allergy, Asthma, and Immunology Virtual Annual Meeting (AAAAI 2023)
San Antonio, Texas 24 February 2023 - 27 February 2023
Alternative treatments for rhinitis could be worth a try
Nasal sprays containing a drug-free aqueous gel emulsion or essential oils appear to help relieve symptoms of allergic rhinitis, as shown in two studies presented at AAAAI 2023.
Alternative treatments for rhinitis could be worth a try
29 Mar 2023
Promising treatment options for chronic hives on the horizon
Dupilumab, barzolvolimab, and remibrutinib appear to help reduce disease activity in patients with chronic spontaneous urticaria, according to the results of three studies presented at AAAAI 2023.
Promising treatment options for chronic hives on the horizon
28 Mar 2023
Oral, on-the-skin immunotherapies show promise against peanut allergy in children
Children who are allergic to peanuts may benefit from two immunotherapies, one oral and another epicutaneous or on-the-skin, which have demonstrated safety and efficacy in separate studies presented at the recent AAAAI 2023.
Oral, on-the-skin immunotherapies show promise against peanut allergy in children
27 Mar 2023
Long-term dupilumab proven safe, effective in children with asthma
Long-term treatment with dupilumab is well tolerated, and its efficacy in children with uncontrolled, moderate-to-severe asthma as seen in the VOYAGE study is consistent, according to the EXCURSION open-label extension study. In addition, patients who switched from placebo to dupilumab has improved rapid lung function.
